Bailard, Inc.

Source: SEC Form 13F · as of Mar 2026

Bailard, Inc. holds 45 biotech & pharma companies tracked by BioSniper, totaling $265.4M in value as of Mar 2026 (SEC Form 13F).

Companies held

45

Total value held

$265.4M

CompanySharesValue
GILDGILEAD SCIENCES, INC.731,497$101.9M
JNJJOHNSON & JOHNSON149,011$36.4M
AMGNAMGEN INC49,711$17.5M
VRTXVERTEX PHARMACEUTICALS INC / MA37,862$16.9M
AZNASTRAZENECA PLC78,509$15.5M
UNHUnitedHealth Group Incorporated Common Stock (DE)53,397$14.4M
LLYELI LILLY & Co13,534$12.4M
ABBVAbbVie Inc.53,382$11.6M
ABTABBOTT LABORATORIES86,009$8.8M
ZTSZoetis Inc.52,836$6.2M
MRKMerck & Co., Inc.24,509$2.9M
CAHCardinal Health Inc.12,467$2.6M
REGNREGENERON PHARMACEUTICALS, INC.3,378$2.6M
NVSNovartis AG13,282$2.0M
MCKMcKesson Corporation2,242$1.9M
SNYSanofi28,791$1.4M
ELVElevance Health Inc.4,551$1.3M
IDXXIDEXX LABORATORIES INC /DE2,153$1.2M
PFEPFIZER INC42,754$1.2M
DGXQuest Diagnostics Incorporated5,545$1.1M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)18,617$1.0M
NEOGNEOGEN CORP40,500$376K
BMYBRISTOL MYERS SQUIBB CO5,824$353K
PAHCPHIBRO ANIMAL HEALTH CORP5,300$293K
LGNDLigand Pharmaceuticals Incorporated1,400$280K
PMPhilip Morris International Inc1,625$269K
NVONovo Nordisk A/S6,945$255K
INVAInnoviva, Inc.10,933$255K
MEDPMedpace Holdings Inc.450$216K
ERASErasca, Inc.13,146$213K
ZVRAZEVRA THERAPEUTICS, INC.14,700$137K
NKTXNkarta, Inc.63,400$134K
ARTVArtiva Biotherapeutics, Inc.20,700$133K
CRBPCorbus Pharmaceuticals Holdings, Inc.13,500$127K
NUVBNuvation Bio Inc.27,000$116K
PBYIPUMA BIOTECHNOLOGY, INC.18,100$116K
EBSEmergent BioSolutions Inc.13,600$113K
ORMPORAMED PHARMACEUTICALS INC.32,478$110K
BDTXBlack Diamond Therapeutics, Inc.51,500$110K
WHWKWhitehawk Therapeutics, Inc.31,398$108K
NAGENiagen Bioscience, Inc.23,800$105K
TARAProtara Therapeutics, Inc.18,617$97K
FULCFulcrum Therapeutics, Inc.11,781$90K
ORGOOrganogenesis Holdings Inc.36,812$87K
ICCCIMMUCELL CORP /DE/10,102$64K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Bailard, Inc. — Biotech 13F Holdings & Portfolio | BioSniper